{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:53:47Z","timestamp":1792616027317,"version":"4.5.0"},"reference-count":154,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-01950-4","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T06:44:05Z","timestamp":1740725045000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The research progress on meningeal metastasis in solid tumors"],"prefix":"10.1007","volume":"16","author":[{"given":"Yi","family":"Yue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunya","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junkai","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengrui","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"issue":"1","key":"1950_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s40263-022-00975-5","volume":"37","author":"JA Wilcox","year":"2023","unstructured":"Wilcox JA, Boire AA. Leveraging Molecular and Immune-Based Therapies in Leptomeningeal Metastases. CNS Drugs. 2023;37(1):45\u201367.","journal-title":"CNS Drugs"},{"issue":"6","key":"1950_CR2","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1097\/WCO.0000000000001218","volume":"36","author":"D Primdahl","year":"2023","unstructured":"Primdahl D, Cohen-Nowak A, Kumthekar P. Novel approaches to treatment of leptomeningeal metastases. Curr Opin Neurol. 2023;36(6):592\u2013602.","journal-title":"Curr Opin Neurol"},{"issue":"11","key":"1950_CR3","doi-asserted-by":"publisher","first-page":"5931","DOI":"10.1073\/pnas.1918167117","volume":"117","author":"TY Na","year":"2020","unstructured":"Na TY, Schecterson L, Mendonsa AM, Gumbiner BM. The functional activity of E-cadherin controls tumor cell metastasis at multiple steps. Proc Natl Acad Sci U S A. 2020;117(11):5931\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1950_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lfs.2017.12.020","volume":"194","author":"ZF Jiang","year":"2018","unstructured":"Jiang ZF, Wang M, Xu JL. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer. Life Sci. 2018;194:1\u20136.","journal-title":"Life Sci"},{"issue":"2","key":"1950_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41568-022-00536-4","volume":"23","author":"A Ring","year":"2023","unstructured":"Ring A, Nguyen-Str\u00e4uli BD, Wicki A, Aceto N. Biology, vulnerabilities and clinical applications of circulating tumour cells. Nat Rev Cancer. 2023;23(2):95\u2013111.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1950_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41591-020-01195-4","volume":"27","author":"K Ganesh","year":"2021","unstructured":"Ganesh K, Massagu\u00e9 J. Targeting metastatic cancer. Nat Med. 2021;27(1):34\u201344.","journal-title":"Nat Med"},{"issue":"1","key":"1950_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/PAP.0000000000000219","volume":"26","author":"M Akhtar","year":"2019","unstructured":"Akhtar M, Haider A, Rashid S, Al-Nabet A. Paget\u2019s, \u201cSeed and Soil\u201d theory of cancer metastasis: an idea whose time has come. Adv Anat Pathol. 2019;26(1):69\u201374.","journal-title":"Adv Anat Pathol"},{"issue":"6","key":"1950_CR8","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.3892\/ol.2014.1979","volume":"7","author":"L Wang","year":"2014","unstructured":"Wang L, Wang Z, Liu X, Liu F. High-level C-X-C chemokine receptor type 4 expression correlates with brain-specific metastasis following complete resection of non-small cell lung cancer. Oncol Lett. 2014;7(6):1871\u20136.","journal-title":"Oncol Lett"},{"issue":"1","key":"1950_CR9","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.bbrc.2014.06.018","volume":"450","author":"MA Davare","year":"2014","unstructured":"Davare MA, Lal S, Peckham JL, Prajapati SI, Gultekin SH, Rubin BP, et al. Secreted meningeal chemokines, but not VEGFA, modulate the migratory properties of medulloblastoma cells. Biochem Biophys Res Commun. 2014;450(1):555\u201360.","journal-title":"Biochem Biophys Res Commun"},{"key":"1950_CR10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13046-015-0264-0","volume":"34","author":"TG Simonsen","year":"2015","unstructured":"Simonsen TG, Gaustad JV, Rofstad EK. Intertumor heterogeneity in vascularity and invasiveness of artificial melanoma brain metastases. J Exp Clin Cancer Res. 2015;34:150.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"1950_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2003.12.016","volume":"16","author":"P Ballabh","year":"2004","unstructured":"Ballabh P, Braun A, Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis. 2004;16(1):1\u201313.","journal-title":"Neurobiol Dis"},{"key":"1950_CR12","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.bbi.2022.11.001","volume":"107","author":"L Xie","year":"2023","unstructured":"Xie L, Zhang S, Huang L, Peng Z, Lu H, He Q, et al. Single-cell RNA sequencing of peripheral blood reveals that monocytes with high cathepsin S expression aggravate cerebral ischemia-reperfusion injury. Brain Behav Immun. 2023;107:330\u201344.","journal-title":"Brain Behav Immun"},{"issue":"9","key":"1950_CR13","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/ncb3011","volume":"16","author":"L Sevenich","year":"2014","unstructured":"Sevenich L, Bowman RL, Mason SD, Quail DF, Rapaport F, Elie BT, et al. Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S. Nat Cell Biol. 2014;16(9):876\u201388.","journal-title":"Nat Cell Biol"},{"issue":"3","key":"1950_CR14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10585-005-8115-6","volume":"22","author":"O Mendes","year":"2005","unstructured":"Mendes O, Kim HT, Stoica G. Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model. Clin Exp Metastasis. 2005;22(3):237\u201346.","journal-title":"Clin Exp Metastasis"},{"issue":"5","key":"1950_CR15","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10585-007-9071-0","volume":"24","author":"O Mendes","year":"2007","unstructured":"Mendes O, Kim HT, Lungu G, Stoica G. MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1\/2. Clin Exp Metastasis. 2007;24(5):341\u201351.","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"1950_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11060-006-9207-0","volume":"81","author":"AM Stark","year":"2007","unstructured":"Stark AM, Anuszkiewicz B, Mentlein R, Yoneda T, Mehdorn HM, Held-Feindt J. Differential expression of matrix metalloproteinases in brain- and bone-seeking clones of metastatic MDA-MB-231 breast cancer cells. J Neurooncol. 2007;81(1):39\u201348.","journal-title":"J Neurooncol"},{"issue":"1","key":"1950_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12974-018-1389-9","volume":"16","author":"S Qiao","year":"2019","unstructured":"Qiao S, Qian Y, Xu G, Luo Q, Zhang Z. Long-term characterization of activated microglia\/macrophages facilitating the development of experimental brain metastasis through intravital microscopic imaging. J Neuroinflammation. 2019;16(1):4.","journal-title":"J Neuroinflammation"},{"issue":"17","key":"1950_CR18","doi-asserted-by":"publisher","first-page":"6674","DOI":"10.1073\/pnas.1117412109","volume":"109","author":"S Serres","year":"2012","unstructured":"Serres S, Soto MS, Hamilton A, McAteer MA, Carbonell WS, Robson MD, et al. Molecular MRI enables early and sensitive detection of brain metastases. Proc Natl Acad Sci U S A. 2012;109(17):6674\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1950_CR19","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/neuonc\/not222","volume":"16","author":"MS Soto","year":"2014","unstructured":"Soto MS, Serres S, Anthony DC, Sibson NR. Functional role of endothelial adhesion molecules in the early stages of brain metastasis. Neuro Oncol. 2014;16(4):540\u201351.","journal-title":"Neuro Oncol"},{"issue":"7","key":"1950_CR20","doi-asserted-by":"publisher","first-page":"E1540","DOI":"10.1073\/pnas.1714089115","volume":"115","author":"D Taggart","year":"2018","unstructured":"Taggart D, Andreou T, Scott KJ, Williams J, Rippaus N, Brownlie RJ, et al. Anti-PD-1\/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8(+) T cell trafficking. Proc Natl Acad Sci U S A. 2018;115(7):E1540\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"1950_CR21","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1158\/2326-6066.CIR-17-0190","volume":"5","author":"AN Woods","year":"2017","unstructured":"Woods AN, Wilson AL, Srivinisan N, Zeng J, Dutta AB, Peske JD, et al. differential expression of homing receptor ligands on tumor-associated vasculature that control cd8 effector t-cell entry. Cancer Immunol Res. 2017;5(12):1062\u201373.","journal-title":"Cancer Immunol Res"},{"issue":"4","key":"1950_CR22","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00401-018-1806-2","volume":"135","author":"DAM Mustafa","year":"2018","unstructured":"Mustafa DAM, Pedrosa R, Smid M, van der Weiden M, de Weerd V, Nigg AL, et al. T lymphocytes facilitate brain metastasis of breast cancer by inducing Guanylate-Binding Protein 1 expression. Acta Neuropathol. 2018;135(4):581\u201399.","journal-title":"Acta Neuropathol"},{"key":"1950_CR23","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.83272","author":"J Li","year":"2022","unstructured":"Li J, Huang D, Lei B, Huang J, Yang L, Nie M, et al. VLA-4 suppression by senescence signals regulates meningeal immunity and leptomeningeal metastasis. Elife. 2022. https:\/\/doi.org\/10.7554\/eLife.83272.","journal-title":"Elife"},{"issue":"6","key":"1950_CR24","doi-asserted-by":"publisher","first-page":"5321","DOI":"10.1007\/s12035-017-0769-y","volume":"55","author":"N Caporarello","year":"2018","unstructured":"Caporarello N, Olivieri M, Cristaldi M, Scalia M, Toscano MA, Genovese C, et al. Blood-brain barrier in a haemophilus influenzae type a in vitro infection: role of adenosine receptors A(2A) and A(2B). Mol Neurobiol. 2018;55(6):5321\u201336.","journal-title":"Mol Neurobiol"},{"issue":"7","key":"1950_CR25","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1097\/01.inf.0000131634.57368.45","volume":"23","author":"M van der Flier","year":"2004","unstructured":"van der Flier M, Hoppenreijs S, van Rensburg AJ, Ruyken M, Kolk AH, Springer P, et al. Vascular endothelial growth factor and blood-brain barrier disruption in tuberculous meningitis. Pediatr Infect Dis J. 2004;23(7):608\u201313.","journal-title":"Pediatr Infect Dis J"},{"key":"1950_CR26","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20212121","author":"ME Freret","year":"2024","unstructured":"Freret ME, Boire A. The anatomic basis of leptomeningeal metastasis. J Exp Med. 2024. https:\/\/doi.org\/10.1084\/jem.20212121.","journal-title":"J Exp Med"},{"issue":"3","key":"1950_CR27","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00401-018-1807-1","volume":"135","author":"JF Ghersi-Egea","year":"2018","unstructured":"Ghersi-Egea JF, Strazielle N, Catala M, Silva-Vargas V, Doetsch F, Engelhardt B. Molecular anatomy and functions of the choroidal blood-cerebrospinal fluid barrier in health and disease. Acta Neuropathol. 2018;135(3):337\u201361.","journal-title":"Acta Neuropathol"},{"issue":"2\u20133","key":"1950_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1023\/A:1005954002922","volume":"38","author":"M Mareel","year":"1998","unstructured":"Mareel M, Leroy A, Bracke M. Cellular and molecular mechanisms of metastasis as applied to carcinomatous meningitis. J Neurooncol. 1998;38(2\u20133):97\u2013102.","journal-title":"J Neurooncol"},{"issue":"6","key":"1950_CR29","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.cell.2017.02.025","volume":"168","author":"A Boire","year":"2017","unstructured":"Boire A, Zou Y, Shieh J, Macalinao DG, Pentsova E, Massagu\u00e9 J. Complement component 3 adapts the cerebrospinal fluid for leptomeningeal metastasis. Cell. 2017;168(6):1101-13.e13.","journal-title":"Cell"},{"issue":"39","key":"1950_CR30","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1038\/s41388-023-02769-5","volume":"42","author":"JK Pan","year":"2023","unstructured":"Pan JK, Lin WD, Kuo YL, Chen YC, Loh ZJ, Lin FC, et al. ICAM2 initiates trans-blood-CSF barrier migration and stemness properties in leptomeningeal metastasis of triple-negative breast cancer. Oncogene. 2023;42(39):2919\u201331.","journal-title":"Oncogene"},{"issue":"6","key":"1950_CR31","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/s41593-019-0393-4","volume":"22","author":"H Van Hove","year":"2019","unstructured":"Van Hove H, Martens L, Scheyltjens I, De Vlaminck K, Pombo Antunes AR, De Prijck S, et al. A single-cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment. Nat Neurosci. 2019;22(6):1021\u201335.","journal-title":"Nat Neurosci"},{"issue":"1","key":"1950_CR32","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/CORR.0000000000001449","volume":"479","author":"T Shimizu","year":"2021","unstructured":"Shimizu T, Demura S, Kato S, Shinmura K, Yokogawa N, Yonezawa N, et al. Radiation disrupts the protective function of the spinal meninges in a mouse model of tumor-induced spinal cord compression. Clin Orthop Relat Res. 2021;479(1):163\u201376.","journal-title":"Clin Orthop Relat Res"},{"issue":"6","key":"1950_CR33","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1093\/neuros\/nyx626","volume":"83","author":"NJ Szerlip","year":"2018","unstructured":"Szerlip NJ, Calinescu A, Smith E, Tagett R, Clines KL, Moon HH, et al. Dural cells release factors which promote cancer cell malignancy and induce immunosuppressive markers in bone marrow myeloid cells. Neurosurgery. 2018;83(6):1306\u201316.","journal-title":"Neurosurgery"},{"issue":"88","key":"1950_CR34","doi-asserted-by":"publisher","first-page":"6155","DOI":"10.1126\/sciimmunol.adg6155","volume":"8","author":"YC Kim","year":"2023","unstructured":"Kim YC, Ahn JH, Jin H, Yang MJ, Hong SP, Yoon JH, et al. Immaturity of immune cells around the dural venous sinuses contributes to viral meningoencephalitis in neonates. Sci Immunol. 2023;8(88):6155.","journal-title":"Sci Immunol."},{"issue":"8002","key":"1950_CR35","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41586-023-06993-7","volume":"627","author":"LCD Smyth","year":"2024","unstructured":"Smyth LCD, Xu D, Okar SV, Dykstra T, Rustenhoven J, Papadopoulos Z, et al. Identification of direct connections between the dura and the brain. Nature. 2024;627(8002):165\u201373.","journal-title":"Nature"},{"key":"1950_CR36","doi-asserted-by":"publisher","first-page":"6553","DOI":"10.1126\/science.abf7844","volume":"373","author":"A Cugurra","year":"2021","unstructured":"Cugurra A, Mamuladze T, Rustenhoven J, Dykstra T, Beroshvili G, Greenberg ZJ, et al. Skull and vertebral bone marrow are myeloid cell reservoirs for the meninges and CNS parenchyma. Science. 2021;373:6553.","journal-title":"Science"},{"issue":"21","key":"1950_CR37","doi-asserted-by":"publisher","first-page":"8788","DOI":"10.1158\/0008-5472.CAN-08-2135","volume":"68","author":"RB Corcoran","year":"2008","unstructured":"Corcoran RB, Bachar Raveh T, Barakat MT, Lee EY, Scott MP. Insulin-like growth factor 2 is required for progression to advanced medulloblastoma in patched1 heterozygous mice. Cancer Res. 2008;68(21):8788\u201395.","journal-title":"Cancer Res"},{"issue":"1","key":"1950_CR38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000274458","volume":"32","author":"C Fernandez","year":"2010","unstructured":"Fernandez C, Tatard VM, Bertrand N, Dahmane N. Differential modulation of Sonic-hedgehog-induced cerebellar granule cell precursor proliferation by the IGF signaling network. Dev Neurosci. 2010;32(1):59\u201370.","journal-title":"Dev Neurosci"},{"issue":"51","key":"1950_CR39","doi-asserted-by":"publisher","first-page":"37170","DOI":"10.1074\/jbc.M705414200","volume":"282","author":"R Alvarez-Rodr\u00edguez","year":"2007","unstructured":"Alvarez-Rodr\u00edguez R, Barzi M, Berenguer J, Pons S. Bone morphogenetic protein 2 opposes Shh-mediated proliferation in cerebellar granule cells through a TIEG-1-based regulation of Nmyc. J Biol Chem. 2007;282(51):37170\u201380.","journal-title":"J Biol Chem"},{"key":"1950_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.745893","volume":"12","author":"H Najem","year":"2021","unstructured":"Najem H, Marisetty A, Horbinski C, Long J, Huse JT, Glitza Oliva IC, et al. CD11c+CD163+ cells and signal transducer and activator of transcription 3 (STAT3) expression are common in melanoma leptomeningeal disease. Front Immunol. 2021;12: 745893.","journal-title":"Front Immunol"},{"issue":"6","key":"1950_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.885","volume":"12","author":"H Ruan","year":"2022","unstructured":"Ruan H, Wang Z, Sun Z, Wei J, Zhang L, Ju H, et al. Single-cell RNA sequencing reveals the characteristics of cerebrospinal fluid tumour environment in breast cancer and lung cancer leptomeningeal metastases. Clin Transl Med. 2022;12(6): e885.","journal-title":"Clin Transl Med"},{"issue":"2","key":"1950_CR42","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1182\/blood-2007-08-104877","volume":"111","author":"J Haas","year":"2008","unstructured":"Haas J, Schopp L, Storch-Hagenlocher B, Fritzsching B, Jacobi C, Milkova L, et al. Specific recruitment of regulatory T cells into the CSF in lymphomatous and carcinomatous meningitis. Blood. 2008;111(2):761\u20136.","journal-title":"Blood"},{"issue":"1","key":"1950_CR43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12974-024-03059-x","volume":"21","author":"R Sun","year":"2024","unstructured":"Sun R, Jiang H. Border-associated macrophages in the central nervous system. J Neuroinflammation. 2024;21(1):67.","journal-title":"J Neuroinflammation"},{"issue":"20","key":"1950_CR44","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.devcel.2023.08.033","volume":"58","author":"NT Pokrajac","year":"2023","unstructured":"Pokrajac NT, Tokarew NJA, Gurdita A, Ortin-Martinez A, Wallace VA. Meningeal macrophages inhibit chemokine signaling in pre-tumor cells to suppress mouse medulloblastoma initiation. Dev Cell. 2023;58(20):2015-31.e8.","journal-title":"Dev Cell"},{"key":"1950_CR45","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.16764","author":"EA Bassett","year":"2016","unstructured":"Bassett EA, Tokarew N, Allemano EA, Mazerolle C, Morin K, Mears AJ, et al. Norrin\/Frizzled4 signalling in the preneoplastic niche blocks medulloblastoma initiation. Elife. 2016. https:\/\/doi.org\/10.7554\/eLife.16764.","journal-title":"Elife"},{"issue":"6501","key":"1950_CR46","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1126\/science.aaz2193","volume":"369","author":"Y Chi","year":"2020","unstructured":"Chi Y, Remsik J, Kiseliovas V, Derderian C, Sener U, Alghader M, et al. Cancer cells deploy lipocalin-2 to collect limiting iron in leptomeningeal metastasis. Science. 2020;369(6501):276\u201382.","journal-title":"Science"},{"issue":"13","key":"1950_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109302","volume":"35","author":"V Martirosian","year":"2021","unstructured":"Martirosian V, Deshpande K, Zhou H, Shen K, Smith K, Northcott P, et al. Medulloblastoma uses GABA transaminase to survive in the cerebrospinal fluid microenvironment and promote leptomeningeal dissemination. Cell Rep. 2021;35(13): 109302.","journal-title":"Cell Rep"},{"issue":"9","key":"1950_CR48","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/cncr.24203","volume":"115","author":"L Nayak","year":"2009","unstructured":"Nayak L, Abrey LE, Iwamoto FM. Intracranial dural metastases. Cancer. 2009;115(9):1947\u201353.","journal-title":"Cancer"},{"issue":"1","key":"1950_CR49","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/1097-0142(19830101)51:1<154::AID-CNCR2820510130>3.0.CO;2-K","volume":"51","author":"CP Kokkoris","year":"1983","unstructured":"Kokkoris CP. Leptomeningeal carcinomatosis How does cancer reach the pia-arachnoid? Cancer. 1983;51(1):154\u201360.","journal-title":"Cancer"},{"issue":"12","key":"1950_CR50","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1002\/1097-0142(19861215)58:12<2656::AID-CNCR2820581218>3.0.CO;2-Q","volume":"58","author":"BG Redman","year":"1986","unstructured":"Redman BG, Tapazoglou E, Al-Sarraf M. Meningeal carcinomatosis in head and neck cancer Report of six cases and review of the literature. Cancer. 1986;58(12):2656.","journal-title":"Cancer"},{"issue":"1","key":"1950_CR51","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1148\/131.1.161","volume":"131","author":"MH Lipper","year":"1979","unstructured":"Lipper MH, Kishore PR. Intraspinal metastases from retinoblastoma. Radiology. 1979;131(1):161\u20133.","journal-title":"Radiology"},{"issue":"1","key":"1950_CR52","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1158\/1078-0432.CCR-17-1582","volume":"24","author":"Y Fan","year":"2018","unstructured":"Fan Y, Zhu X, Xu Y, Lu X, Xu Y, Wang M, et al. Cell-cycle and DNA-damage response pathway is involved in leptomeningeal metastasis of non-small cell lung cancer. Clin Cancer Res. 2018;24(1):209\u201316.","journal-title":"Clin Cancer Res"},{"key":"1950_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS25084416","author":"E Ampudia-Mesias","year":"2024","unstructured":"Ampudia-Mesias E, Cameron CS, Yoo E, Kelly M, Anderson SM, Manning R, et al. The OTX2 gene induces tumor growth and triggers leptomeningeal metastasis by regulating the mTORC2 signaling pathway in group 3 medulloblastomas. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/IJMS25084416.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1950_CR54","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.3324\/haematol.2019.230334","volume":"105","author":"LM Jonart","year":"2020","unstructured":"Jonart LM, Ebadi M, Basile P, Johnson K, Makori J, Gordon PM. Disrupting the leukemia niche in the central nervous system attenuates leukemia chemoresistance. Haematologica. 2020;105(8):2130\u201340.","journal-title":"Haematologica"},{"issue":"15\u201316","key":"1950_CR55","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1101\/gad.348190.120","volume":"35","author":"A Zelco","year":"2021","unstructured":"Zelco A, B\u00f6rjesson V, de Kanter JK, Lebrero-Fernandez C, Lauschke VM, Rocha-Ferreira E, et al. Single-cell atlas reveals meningeal leukocyte heterogeneity in the developing mouse brain. Genes Dev. 2021;35(15\u201316):1190\u2013207.","journal-title":"Genes Dev"},{"issue":"Pt 3","key":"1950_CR56","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1093\/brain\/120.3.435","volume":"120","author":"DC Anthony","year":"1997","unstructured":"Anthony DC, Bolton SJ, Fearn S, Perry VH. Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. Brain. 1997;120(Pt 3):435\u201344.","journal-title":"Brain"},{"key":"1950_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2023.100898","volume":"39","author":"C Cocito","year":"2023","unstructured":"Cocito C, Martin B, Giantini-Larsen AM, Valcarce-Aspegren M, Souweidane MM, Szalontay L, et al. Leptomeningeal dissemination in pediatric brain tumors. Neoplasia. 2023;39: 100898.","journal-title":"Neoplasia"},{"issue":"12","key":"1950_CR58","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s11912-023-01468-4","volume":"25","author":"S Puri","year":"2023","unstructured":"Puri S, Chaudhry A, Bayable A, Ganesh A, Daher A, Gadi VK, et al. Systemic treatment for brain metastasis and leptomeningeal disease in breast cancer patients. Curr Oncol Rep. 2023;25(12):1419\u201330.","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"1950_CR59","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1158\/1078-0432.CCR-22-1585","volume":"29","author":"G Ozcan","year":"2023","unstructured":"Ozcan G, Singh M, Vredenburgh JJ. Leptomeningeal metastasis from non-small cell lung cancer and current landscape of treatments. Clin Cancer Res. 2023;29(1):11\u201329.","journal-title":"Clin Cancer Res"},{"issue":"10412","key":"1950_CR60","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/S0140-6736(23)01054-1","volume":"402","author":"MJ van den Bent","year":"2023","unstructured":"van den Bent MJ, Geurts M, French PJ, Smits M, Capper D, Bromberg JEC, et al. Primary brain tumours in adults. Lancet. 2023;402(10412):1564\u201379.","journal-title":"Lancet"},{"issue":"5","key":"1950_CR61","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41388-021-02056-1","volume":"41","author":"G Alzial","year":"2022","unstructured":"Alzial G, Renoult O, Paris F, Gratas C, Clavreul A, Pecqueur C. Wild-type isocitrate dehydrogenase under the spotlight in glioblastoma. Oncogene. 2022;41(5):613\u201321.","journal-title":"Oncogene"},{"issue":"1","key":"1950_CR62","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10555-021-09997-9","volume":"41","author":"L Barthel","year":"2022","unstructured":"Barthel L, Hadamitzky M, Dammann P, Schedlowski M, Sure U, Thakur BK, et al. Glioma: molecular signature and crossroads with tumor microenvironment. Cancer Metastasis Rev. 2022;41(1):53\u201375.","journal-title":"Cancer Metastasis Rev"},{"issue":"9","key":"1950_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.7206","volume":"13","author":"X Hua","year":"2024","unstructured":"Hua X, Feng W, Ye M, Lai M, Yu X, Sun M, et al. Development and validation of a nomogram to predict leptomeningeal metastases in lung adenocarcinoma: Cervical lymph node metastasis is an important association factor. Cancer Med. 2024;13(9): e7206.","journal-title":"Cancer Med"},{"issue":"1","key":"1950_CR64","doi-asserted-by":"publisher","first-page":"22372","DOI":"10.1038\/s41598-022-26131-z","volume":"12","author":"Q Li","year":"2022","unstructured":"Li Q, Lin Z, Hong Y, Fu Y, Chen Y, Liu T, et al. Brain parenchymal and leptomeningeal metastasis in non-small cell lung cancer. Sci Rep. 2022;12(1):22372.","journal-title":"Sci Rep"},{"issue":"8","key":"1950_CR65","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1093\/neuonc\/noac023","volume":"24","author":"SR Lowe","year":"2022","unstructured":"Lowe SR, Wang CP, Brisco A, Whiting J, Arrington J, Ahmed K, et al. Surgical and anatomic factors predict development of leptomeningeal disease in patients with melanoma brain metastases. Neuro Oncol. 2022;24(8):1307\u201317.","journal-title":"Neuro Oncol"},{"issue":"1","key":"1950_CR66","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0002-9343(84)90738-1","volume":"76","author":"SM de la Monte","year":"1984","unstructured":"de la Monte SM, Hutchins GM, Moore GW. Estrogen and progesterone receptors in prediction of metastatic behavior of breast carcinoma. Am J Med. 1984;76(1):11\u20137.","journal-title":"Am J Med"},{"issue":"2","key":"1950_CR67","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3171\/2022.12.JNS221490","volume":"139","author":"RA Morshed","year":"2023","unstructured":"Morshed RA, Saggi S, Cummins DD, Molinaro AM, Young JS, Viner JA, et al. Identification of risk factors associated with leptomeningeal disease after resection of brain metastases. J Neurosurg. 2023;139(2):402\u201313.","journal-title":"J Neurosurg"},{"issue":"3","key":"1950_CR68","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s11060-023-04381-9","volume":"163","author":"R Otani","year":"2023","unstructured":"Otani R, Sadato D, Yamada R, Yajima H, Kawamura S, Shimizu S, et al. CHD5 gene variant predicts leptomeningeal metastasis after surgical resection of brain metastases of breast cancer. J Neurooncol. 2023;163(3):657\u201362.","journal-title":"J Neurooncol"},{"key":"1950_CR69","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/annonc\/mdx221","volume":"28","author":"E Le Rhun","year":"2017","unstructured":"Le Rhun E, Weller M, Brandsma D, Van den Bent M, de Azambuja E, Henriksson R, et al. EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours. Ann Oncol. 2017;28:84\u201399.","journal-title":"Ann Oncol"},{"issue":"1","key":"1950_CR70","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11060-004-8098-1","volume":"75","author":"F Laigle-Donadey","year":"2005","unstructured":"Laigle-Donadey F, Taillibert S, Mokhtari K, Hildebrand J, Delattre JY. Dural metastases. J Neurooncol. 2005;75(1):57\u201361.","journal-title":"J Neurooncol"},{"issue":"6","key":"1950_CR71","doi-asserted-by":"publisher","first-page":"5080","DOI":"10.3892\/ol.2016.5314","volume":"12","author":"Y Lv","year":"2016","unstructured":"Lv Y, Mu N, Ma C, Jiang R, Wu Q, Li J, et al. Detection value of tumor cells in cerebrospinal fluid in the diagnosis of meningeal metastasis from lung cancer by immuno-FISH technology. Oncol Lett. 2016;12(6):5080\u20134.","journal-title":"Oncol Lett"},{"issue":"9","key":"1950_CR72","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1093\/neuonc\/nox066","volume":"19","author":"X Lin","year":"2017","unstructured":"Lin X, Fleisher M, Rosenblum M, Lin O, Boire A, Briggs S, et al. Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors. Neuro Oncol. 2017;19(9):1248\u201354.","journal-title":"Neuro Oncol"},{"issue":"5","key":"1950_CR73","first-page":"e521","volume":"94","author":"MTJ van Bussel","year":"2020","unstructured":"van Bussel MTJ, Pluim D, Milojkovic Kerklaan B, Bol M, Sikorska K, Linders DTC, et al. Circulating epithelial tumor cell analysis in CSF in patients with leptomeningeal metastases. Neurology. 2020;94(5):e521\u20138.","journal-title":"Neurology"},{"issue":"3","key":"1950_CR74","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s11060-023-04520-2","volume":"165","author":"Q Miao","year":"2023","unstructured":"Miao Q, Zheng X, Li L, Zheng X, Zhang L, Jiang K, et al. Cerebrospinal fluid circulating tumor DNA contributes to the detection and characterization of leptomeningeal metastasis in non-small cell lung cancer. J Neurooncol. 2023;165(3):517\u201325.","journal-title":"J Neurooncol"},{"issue":"18","key":"1950_CR75","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1111\/1759-7714.14592","volume":"13","author":"N Nie","year":"2022","unstructured":"Nie N, Zhou H, Zhang K, Liu L, Luo N, Wang R, et al. Genotyping of cerebrospinal fluid in lung cancer patients with leptomeningeal metastasis. Thorac Cancer. 2022;13(18):2574\u201383.","journal-title":"Thorac Cancer"},{"issue":"1","key":"1950_CR76","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11060-023-04471-8","volume":"165","author":"K Bai","year":"2023","unstructured":"Bai K, Chen X, Qi X, Zhang Y, Zou Y, Li J, et al. Cerebrospinal fluid circulating tumour DNA genotyping and survival analysis in lung adenocarcinoma with leptomeningeal metastases. J Neurooncol. 2023;165(1):149\u201360.","journal-title":"J Neurooncol"},{"issue":"10","key":"1950_CR77","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1158\/1078-0432.CCR-20-3954","volume":"27","author":"L Angus","year":"2021","unstructured":"Angus L, Deger T, Jager A, Martens JWM, de Weerd V, van Heuvel I, et al. Detection of aneuploidy in cerebrospinal fluid from patients with breast cancer can improve diagnosis of leptomeningeal metastases. Clin Cancer Res. 2021;27(10):2798\u2013806.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1950_CR78","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/ijc.28949","volume":"136","author":"YJ An","year":"2015","unstructured":"An YJ, Cho HR, Kim TM, Keam B, Kim JW, Wen H, et al. An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients. Int J Cancer. 2015;136(1):162\u201371.","journal-title":"Int J Cancer"},{"issue":"19","key":"1950_CR79","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1111\/1759-7714.14128","volume":"12","author":"S Song","year":"2021","unstructured":"Song S, Chang D, Li H, Liu C, Li H, Cui Y. Application of optic neuro-ophthalmology imaging in latent meningeal metastases of lung cancer. Thorac Cancer. 2021;12(19):2614\u20137.","journal-title":"Thorac Cancer"},{"issue":"1","key":"1950_CR80","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1186\/s12885-021-08581-2","volume":"21","author":"X Wang","year":"2021","unstructured":"Wang X, Cai J, Zeng Z, Liu A. Efficacy of osimertinib for preventing leptomeningeal metastasis derived from advanced EGFR-mutated non-small cell lung cancer: a propensity-matched retrospective study. BMC Cancer. 2021;21(1):873.","journal-title":"BMC Cancer"},{"issue":"21","key":"1950_CR81","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1056\/NEJMoa2027187","volume":"383","author":"AT Shaw","year":"2020","unstructured":"Shaw AT, Bauer TM, de Marinis F, Felip E, Goto Y, Liu G, et al. First-line Lorlatinib or Crizotinib in advanced ALK-positive lung cancer. N Engl J Med. 2020;383(21):2018\u201329.","journal-title":"N Engl J Med"},{"issue":"11","key":"1950_CR82","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1111\/1759-7714.13962","volume":"12","author":"K Yamamoto","year":"2021","unstructured":"Yamamoto K, Toyokawa G, Kozuma Y, Shoji F, Yamazaki K, Takeo S. ALK-positive lung cancer in a patient with recurrent brain metastases and meningeal dissemination who achieved long-term survival of more than seven years with sequential treatment of five ALK-inhibitors: a case report. Thorac Cancer. 2021;12(11):1761\u20134.","journal-title":"Thorac Cancer"},{"key":"1950_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2023.102653","volume":"122","author":"R Bartsch","year":"2024","unstructured":"Bartsch R, Jerzak KJ, Larrouquere L, M\u00fcller V, Le Rhun E. Pharmacotherapy for leptomeningeal disease in breast cancer. Cancer Treat Rev. 2024;122: 102653.","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"1950_CR84","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/CMR.0000000000000373","volume":"27","author":"V Gr\u00e4tz","year":"2017","unstructured":"Gr\u00e4tz V, L\u00fcttmann N, Haase O, Langan EA, Kemmling A, Zillikens D, et al. Meningeal melanomatosis following discontinuation of dabrafenib: implications for the maintenance of long-term complete remission. Melanoma Res. 2017;27(5):503\u20136.","journal-title":"Melanoma Res"},{"issue":"3","key":"1950_CR85","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.lungcan.2015.06.001","volume":"89","author":"L Gong","year":"2015","unstructured":"Gong L, Xiong M, Huang Z, Miao L, Fan Y. Icotinib might be effective for the treatment of leptomeningeal carcinomatosis in non-small cell lung cancer with sensitive EGFR mutations. Lung Cancer. 2015;89(3):268\u201373.","journal-title":"Lung Cancer"},{"issue":"4","key":"1950_CR86","doi-asserted-by":"publisher","first-page":"e442","DOI":"10.1016\/j.cllc.2019.03.005","volume":"20","author":"M Choi","year":"2019","unstructured":"Choi M, Keam B, Ock CY, Kim M, Kim TM, Kim DW, et al. Pemetrexed in the treatment of leptomeningeal metastasis in patients with EGFR-mutant lung cancer. Clin Lung Cancer. 2019;20(4):e442\u201351.","journal-title":"Clin Lung Cancer"},{"key":"1950_CR87","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.2147\/DDDT.S135711","volume":"11","author":"KH Zhao","year":"2017","unstructured":"Zhao KH, Zhang C, Bai Y, Li Y, Kang X, Chen JX, et al. Antiglioma effects of cytarabine on leptomeningeal metastasis of high-grade glioma by targeting the PI3K\/Akt\/mTOR pathway. Drug Des Devel Ther. 2017;11:1905\u201315.","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"1950_CR88","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1186\/s12885-023-10806-5","volume":"23","author":"T Zhou","year":"2023","unstructured":"Zhou T, Zhu S, Xiong Q, Gan J, Wei J, Cai J, et al. Intrathecal chemotherapy combined with systemic therapy in patients with refractory leptomeningeal metastasis of non-small cell lung cancer: a retrospective study. BMC Cancer. 2023;23(1):333.","journal-title":"BMC Cancer"},{"issue":"2","key":"1950_CR89","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s11060-023-04483-4","volume":"165","author":"Y Hong","year":"2023","unstructured":"Hong Y, Miao Q, Zheng X, Xu Y, Huang Y, Chen S, et al. Effects of intrathecal pemetrexed on the survival of patients with leptomeningeal metastasis from lung adenocarcinoma: a propensity score matching analysis. J Neurooncol. 2023;165(2):301\u201312.","journal-title":"J Neurooncol"},{"issue":"1","key":"1950_CR90","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.clbc.2014.07.004","volume":"15","author":"A Niwi\u0144ska","year":"2015","unstructured":"Niwi\u0144ska A, Rudnicka H, Murawska M. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy. Clin Breast Cancer. 2015;15(1):66\u201372.","journal-title":"Clin Breast Cancer"},{"issue":"18","key":"1950_CR91","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1016\/j.ejca.2004.08.012","volume":"40","author":"W Boogerd","year":"2004","unstructured":"Boogerd W, van den Bent MJ, Koehler PJ, Heimans JJ, van der Sande JJ, Aaronson NK, et al. The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study. Eur J Cancer. 2004;40(18):2726\u201333.","journal-title":"Eur J Cancer"},{"issue":"4","key":"1950_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.102384","volume":"9","author":"C Fan","year":"2024","unstructured":"Fan C, Jiang Z, Teng C, Song X, Li L, Shen W, et al. Efficacy and safety of intrathecal pemetrexed for TKI-failed leptomeningeal metastases from EGFR+ NSCLC: an expanded, single-arm, phase II clinical trial. ESMO Open. 2024;9(4): 102384.","journal-title":"ESMO Open"},{"issue":"2","key":"1950_CR93","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1016\/j.cllc.2022.11.011","volume":"24","author":"H Li","year":"2023","unstructured":"Li H, Zheng S, Lin Y, Yu T, Xie Y, Jiang C, et al. Safety, pharmacokinetic and clinical activity of intrathecal chemotherapy with pemetrexed via the ommaya reservoir for leptomeningeal metastases from lung adenocarcinoma: a prospective phase i study. Clin Lung Cancer. 2023;24(2):e94\u2013104.","journal-title":"Clin Lung Cancer"},{"issue":"Suppl 2","key":"1950_CR94","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2019-000507","volume":"4","author":"E Le Rhun","year":"2019","unstructured":"Le Rhun E, Preusser M, van den Bent M, Andratschke N, Weller M. How we treat patients with leptomeningeal metastases. ESMO Open. 2019;4(Suppl 2): e000507.","journal-title":"ESMO Open"},{"issue":"1","key":"1950_CR95","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00701-024-05989-0","volume":"166","author":"S Jang","year":"2024","unstructured":"Jang S, Gwak HS, Joo J, Doh YS, Shin SH, Yoo H, et al. The efficacy of slow-rate ventriculolumbar perfusion chemotherapy for leptomeningeal carcinomatosis: a phase II study. Acta Neurochir (Wien). 2024;166(1):117.","journal-title":"Acta Neurochir (Wien)"},{"issue":"1","key":"1950_CR96","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1186\/s12885-019-5915-7","volume":"19","author":"J Liu","year":"2019","unstructured":"Liu J, Jin B, Su H, Qu X, Liu Y. Afatinib helped overcome subsequent resistance to osimertinib in a patient with NSCLC having leptomeningeal metastasis baring acquired EGFR L718Q mutation: a case report. BMC Cancer. 2019;19(1):702.","journal-title":"BMC Cancer"},{"issue":"44","key":"1950_CR97","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000027727","volume":"100","author":"M Wang","year":"2021","unstructured":"Wang M, Zhu F, Luo N, Li M, Qi Y, Wang M. Erlotinib combined with bevacizumab and chemotherapy in first line osimertinib-resistant NSCLC patient with leptomeningeal metastasis: a case report. Medicine (Baltimore). 2021;100(44): e27727.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"1950_CR98","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/neuonc\/noac180","volume":"25","author":"F Oberkampf","year":"2023","unstructured":"Oberkampf F, Gutierrez M, Trabelsi Grati O, Le Rhun \u00c9, Tr\u00e9dan O, Turbiez I, et al. Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis. Neuro Oncol. 2023;25(2):365\u201374.","journal-title":"Neuro Oncol"},{"issue":"3","key":"1950_CR99","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s10549-011-1417-2","volume":"127","author":"M Oliveira","year":"2011","unstructured":"Oliveira M, Braga S, Passos-Coelho JL, Fonseca R, Oliveira J. Complete response in HER2+ leptomeningeal carcinomatosis from breast cancer with intrathecal trastuzumab. Breast Cancer Res Treat. 2011;127(3):841\u20134.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"1950_CR100","doi-asserted-by":"publisher","first-page":"843","DOI":"10.4143\/crt.2014.234","volume":"48","author":"WY Park","year":"2016","unstructured":"Park WY, Kim HJ, Kim K, Bae SB, Lee N, Lee KT, et al. Intrathecal trastuzumab treatment in patients with breast cancer and leptomeningeal carcinomatosis. Cancer Res Treat. 2016;48(2):843\u20137.","journal-title":"Cancer Res Treat"},{"issue":"Supplement","key":"1950_CR101","first-page":"C181","volume":"12","author":"Y Ju","year":"2016","unstructured":"Ju Y, Wang J, Sun S, Jiao S. Nimotuzumab treatment and outcome analysis in patients with leptomeningeal metastasis from nonsmall cell lung cancer. J Cancer Res Ther. 2016;12(Supplement):C181\u20135.","journal-title":"J Cancer Res Ther"},{"key":"1950_CR102","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1136\/jitc-2021-002473","volume":"9","author":"J Naidoo","year":"2021","unstructured":"Naidoo J, Schreck KC, Fu W, Hu C, Carvajal-Gonzalez A, Connolly RM, et al. Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers. J Immunother Cancer. 2021;9:8.","journal-title":"J Immunother Cancer"},{"key":"1950_CR103","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.lungcan.2017.02.022","volume":"108","author":"M Gion","year":"2017","unstructured":"Gion M, Remon J, Caramella C, Soria JC, Besse B. Symptomatic leptomeningeal metastasis improvement with nivolumab in advanced non-small cell lung cancer patient. Lung Cancer. 2017;108:72\u20134.","journal-title":"Lung Cancer"},{"issue":"8","key":"1950_CR104","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/s41591-020-0918-0","volume":"26","author":"PK Brastianos","year":"2020","unstructured":"Brastianos PK, Lee EQ, Cohen JV, Tolaney SM, Lin NU, Wang N, et al. Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis. Nat Med. 2020;26(8):1280\u20134.","journal-title":"Nat Med"},{"issue":"6","key":"1950_CR105","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155315","volume":"11","author":"MC Burger","year":"2016","unstructured":"Burger MC, Zeiner PS, Jahnke K, Wagner M, Mittelbronn M, Steinbach JP. Addition of anti-angiogenetic therapy with bevacizumab to chemo- and radiotherapy for leptomeningeal metastases in primary brain tumors. PLoS ONE. 2016;11(6): e0155315.","journal-title":"PLoS ONE"},{"issue":"4","key":"1950_CR106","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1158\/1535-7163.MCT-15-0582","volume":"15","author":"A Ilhan-Mutlu","year":"2016","unstructured":"Ilhan-Mutlu A, Osswald M, Liao Y, G\u00f6mmel M, Reck M, Miles D, et al. Bevacizumab prevents brain metastases formation in lung adenocarcinoma. Mol Cancer Ther. 2016;15(4):702\u201310.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"1950_CR107","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12967-020-02212-3","volume":"18","author":"TG Simonsen","year":"2020","unstructured":"Simonsen TG, Gaustad JV, Rofstad EK. Bevacizumab treatment of meningeal melanoma metastases. J Transl Med. 2020;18(1):13.","journal-title":"J Transl Med"},{"issue":"1","key":"1950_CR108","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11060-011-0655-9","volume":"106","author":"PK Brastianos","year":"2012","unstructured":"Brastianos PK, Brastianos HC, Hsu W, Sciubba DM, Kosztowski T, Tyler BM, et al. The toxicity of intrathecal bevacizumab in a rabbit model of leptomeningeal carcinomatosis. J Neurooncol. 2012;106(1):81\u20138.","journal-title":"J Neurooncol"},{"issue":"1","key":"1950_CR109","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s11060-023-04412-5","volume":"164","author":"M Holdaway","year":"2023","unstructured":"Holdaway M, Ablyazova F, Huda S, D\u2019Amico RS, Wong T, Shani D, et al. First in-human intrathecal delivery of bevacizumab for leptomeningeal spread from recurrent glioblastoma: rationale for a dose escalation trial. J Neurooncol. 2023;164(1):231\u20137.","journal-title":"J Neurooncol"},{"issue":"5","key":"1950_CR110","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.clbc.2019.04.004","volume":"19","author":"MM Mrugala","year":"2019","unstructured":"Mrugala MM, Kim B, Sharma A, Johnson N, Graham C, Kurland BF, et al. Phase II study of systemic high-dose methotrexate and intrathecal liposomal cytarabine for treatment of leptomeningeal carcinomatosis from breast cancer. Clin Breast Cancer. 2019;19(5):311\u20136.","journal-title":"Clin Breast Cancer"},{"key":"1950_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119342","volume":"218","author":"UK Sukumar","year":"2019","unstructured":"Sukumar UK, Bose RJC, Malhotra M, Babikir HA, Afjei R, Robinson E, et al. Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide. Biomaterials. 2019;218: 119342.","journal-title":"Biomaterials"},{"issue":"2","key":"1950_CR112","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1208\/s12249-021-01928-9","volume":"22","author":"K Wiwatchaitawee","year":"2021","unstructured":"Wiwatchaitawee K, Quarterman JC, Geary SM, Salem AK. Enhancement of therapies for glioblastoma (GBM) using nanoparticle-based delivery systems. AAPS PharmSciTech. 2021;22(2):71.","journal-title":"AAPS PharmSciTech"},{"key":"1950_CR113","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1186\/s12885-015-1672-4","volume":"15","author":"CE Adkins","year":"2015","unstructured":"Adkins CE, Nounou MI, Hye T, Mohammad AS, Terrell-Hall T, Mohan NK, et al. NKTR-102 efficacy versus irinotecan in a mouse model of brain metastases of breast cancer. BMC Cancer. 2015;15:685.","journal-title":"BMC Cancer"},{"issue":"3","key":"1950_CR114","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s10549-020-05995-7","volume":"185","author":"JC Sachdev","year":"2021","unstructured":"Sachdev JC, Munster P, Northfelt DW, Han HS, Ma C, Maxwell F, et al. Phase I study of liposomal irinotecan in patients with metastatic breast cancer: findings from the expansion phase. Breast Cancer Res Treat. 2021;185(3):759\u201371.","journal-title":"Breast Cancer Res Treat"},{"issue":"20","key":"1950_CR115","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.1158\/1078-0432.CCR-16-0399","volume":"22","author":"P Ballard","year":"2016","unstructured":"Ballard P, Yates JW, Yang Z, Kim DW, Yang JC, Cantarini M, et al. Preclinical comparison of osimertinib with other EGFR-TKIs in EGFR-mutant NSCLC brain metastases models, and early evidence of clinical brain metastases activity. Clin Cancer Res. 2016;22(20):5130\u201340.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1950_CR116","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1021\/jm040114b","volume":"48","author":"A Rice","year":"2005","unstructured":"Rice A, Liu Y, Michaelis ML, Himes RH, Georg GI, Audus KL. Chemical modification of paclitaxel (Taxol) reduces P-glycoprotein interactions and increases permeation across the blood-brain barrier in vitro and in situ. J Med Chem. 2005;48(3):832\u20138.","journal-title":"J Med Chem"},{"issue":"8","key":"1950_CR117","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1021\/acs.molpharmaceut.9b00018","volume":"16","author":"IC Salaroglio","year":"2019","unstructured":"Salaroglio IC, Abate C, Rolando B, Battaglia L, Gazzano E, Colombino E, et al. Validation of thiosemicarbazone compounds as p-glycoprotein inhibitors in human primary brain-blood barrier and glioblastoma stem cells. Mol Pharm. 2019;16(8):3361\u201373.","journal-title":"Mol Pharm"},{"issue":"7","key":"1950_CR118","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1111\/j.1476-5381.2012.02103.x","volume":"167","author":"M Pinz\u00f3n-Daza","year":"2012","unstructured":"Pinz\u00f3n-Daza M, Garz\u00f3n R, Couraud P, Romero I, Weksler B, Ghigo D, et al. The association of statins plus LDL receptor-targeted liposome-encapsulated doxorubicin increases in vitro drug delivery across blood-brain barrier cells. Br J Pharmacol. 2012;167(7):1431\u201347.","journal-title":"Br J Pharmacol"},{"issue":"4","key":"1950_CR119","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/S0360-3016(01)01735-7","volume":"51","author":"D Qin","year":"2001","unstructured":"Qin D, Ou G, Mo H, Song Y, Kang G, Hu Y, et al. Improved efficacy of chemotherapy for glioblastoma by radiation-induced opening of blood-brain barrier: clinical results. Int J Radiat Oncol Biol Phys. 2001;51(4):959\u201362.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"1950_CR120","doi-asserted-by":"publisher","first-page":"910","DOI":"10.2174\/0115680096276133231201061114","volume":"24","author":"Y Meng","year":"2024","unstructured":"Meng Y, Zhu M, Yang J, Wang X, Liang Y, Yu M, et al. Treatment advances in lung cancer with leptomeningeal metastasis. Curr Cancer Drug Targets. 2024;24(9):910.","journal-title":"Curr Cancer Drug Targets"},{"issue":"1","key":"1950_CR121","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13014-019-1376-z","volume":"14","author":"W Yan","year":"2019","unstructured":"Yan W, Liu Y, Li J, Han A, Kong L, Yu J, et al. Whole brain radiation therapy does not improve the overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastasis. Radiat Oncol. 2019;14(1):168.","journal-title":"Radiat Oncol"},{"issue":"7","key":"1950_CR122","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1007\/s10147-020-01668-z","volume":"25","author":"Y Hirano","year":"2020","unstructured":"Hirano Y, Konishi K, Ejima Y. Utility of whole brain radiation therapy for leptomeningeal carcinomatosis. Int J Clin Oncol. 2020;25(7):1432\u20139.","journal-title":"Int J Clin Oncol"},{"issue":"5","key":"1950_CR123","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s10585-023-10225-7","volume":"40","author":"H Oyoshi","year":"2023","unstructured":"Oyoshi H, Hirata H, Hirano Y, Zenda S, Zhou Y, Tomizawa K, et al. Prognostic impact of EGFR\/ALK alterations in leptomeningeal metastasis from lung adenocarcinoma treated with whole-brain radiotherapy. Clin Exp Metastasis. 2023;40(5):407\u201313.","journal-title":"Clin Exp Metastasis"},{"issue":"5","key":"1950_CR124","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00066-022-01910-9","volume":"198","author":"S Iglseder","year":"2022","unstructured":"Iglseder S, Nowosielski M, Bsteh G, Muigg A, Heugenhauser J, Mayer E, et al. Whole brain radiotherapy combined with intrathecal liposomal cytarabine for leptomeningeal metastasis-a safety analysis and validation of the EANO-ESMO classification. Strahlenther Onkol. 2022;198(5):475\u201383.","journal-title":"Strahlenther Onkol"},{"issue":"33","key":"1950_CR125","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.1200\/JCO.22.01148","volume":"40","author":"JT Yang","year":"2022","unstructured":"Yang JT, Wijetunga NA, Pentsova E, Wolden S, Young RJ, Correa D, et al. Randomized phase II trial of proton craniospinal irradiation versus photon involved-field radiotherapy for patients with solid tumor leptomeningeal metastasis. J Clin Oncol. 2022;40(33):3858\u201367.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1950_CR126","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s11060-023-04523-z","volume":"166","author":"MA Garcia","year":"2024","unstructured":"Garcia MA, Turner A, Brachman DG. The role of GammaTile in the treatment of brain tumors: a technical and clinical overview. J Neurooncol. 2024;166(2):203\u201312.","journal-title":"J Neurooncol"},{"issue":"18","key":"1950_CR127","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1200\/JCO.2005.07.144","volume":"23","author":"Y Cao","year":"2005","unstructured":"Cao Y, Tsien CI, Shen Z, Tatro DS, Ten Haken R, Kessler ML, et al. Use of magnetic resonance imaging to assess blood-brain\/blood-glioma barrier opening during conformal radiotherapy. J Clin Oncol. 2005;23(18):4127\u201336.","journal-title":"J Clin Oncol"},{"issue":"Pt B","key":"1950_CR128","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jchemneu.2015.12.010","volume":"75","author":"B S\u0131rav","year":"2016","unstructured":"S\u0131rav B, Seyhan N. Effects of GSM modulated radio-frequency electromagnetic radiation on permeability of blood-brain barrier in male & female rats. J Chem Neuroanat. 2016;75(Pt B):123\u20137.","journal-title":"J Chem Neuroanat"},{"issue":"2","key":"1950_CR129","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/lsm.10181","volume":"33","author":"M Sabel","year":"2003","unstructured":"Sabel M, Rommel F, Kondakci M, Gorol M, Willers R, Bilzer T. Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Lasers Surg Med. 2003;33(2):75\u201380.","journal-title":"Lasers Surg Med"},{"issue":"7","key":"1950_CR130","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.ultrasmedbio.2004.04.010","volume":"30","author":"N Sheikov","year":"2004","unstructured":"Sheikov N, McDannold N, Vykhodtseva N, Jolesz F, Hynynen K. Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles. Ultrasound Med Biol. 2004;30(7):979\u201389.","journal-title":"Ultrasound Med Biol"},{"issue":"16","key":"1950_CR131","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.7150\/thno.21630","volume":"7","author":"D McMahon","year":"2017","unstructured":"McMahon D, Hynynen K. Acute inflammatory response following increased blood-brain barrier permeability induced by focused ultrasound is dependent on microbubble dose. Theranostics. 2017;7(16):3989\u20134000.","journal-title":"Theranostics"},{"issue":"1\u20132","key":"1950_CR132","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jconrel.2013.04.007","volume":"169","author":"M Aryal","year":"2013","unstructured":"Aryal M, Vykhodtseva N, Zhang YZ, Park J, McDannold N. Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model. J Control Release. 2013;169(1\u20132):103\u201311.","journal-title":"J Control Release"},{"key":"1950_CR133","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jconrel.2018.05.005","volume":"281","author":"S Alli","year":"2018","unstructured":"Alli S, Figueiredo CA, Golbourn B, Sabha N, Wu MY, Bondoc A, et al. Brainstem blood brain barrier disruption using focused ultrasound: a demonstration of feasibility and enhanced doxorubicin delivery. J Control Release. 2018;281:29\u201341.","journal-title":"J Control Release"},{"issue":"21","key":"1950_CR134","doi-asserted-by":"publisher","first-page":"6284","DOI":"10.7150\/thno.35892","volume":"9","author":"N McDannold","year":"2019","unstructured":"McDannold N, Zhang Y, Supko JG, Power C, Sun T, Peng C, et al. Acoustic feedback enables safe and reliable carboplatin delivery across the blood-brain barrier with a clinical focused ultrasound system and improves survival in a rat glioma model. Theranostics. 2019;9(21):6284\u201399.","journal-title":"Theranostics"},{"issue":"1","key":"1950_CR135","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11060-020-03510-y","volume":"148","author":"TW Chen","year":"2020","unstructured":"Chen TW, Jan IS, Chang DY, Lin CH, Chen IC, Chen HM, et al. Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival. J Neurooncol. 2020;148(1):165\u201372.","journal-title":"J Neurooncol"},{"issue":"2","key":"1950_CR136","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/1759-7714.13738","volume":"12","author":"ZQ Lu","year":"2021","unstructured":"Lu ZQ, Cai J, Wang X, Wei JP, Zeng ZM, Huang L, et al. Osimertinib combined with bevacizumab for leptomeningeal metastasis from EGFR-mutation non-small cell lung cancer: a phase II single-arm prospective clinical trial. Thorac Cancer. 2021;12(2):172\u201380.","journal-title":"Thorac Cancer"},{"key":"1950_CR137","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.lungcan.2016.07.008","volume":"99","author":"Y Sakata","year":"2016","unstructured":"Sakata Y, Kawamura K, Shingu N, Ichikado K. Erlotinib plus bevacizumab as an effective treatment for leptomeningeal metastases from EGFR mutation-positive non-small cell lung cancer. Lung Cancer. 2016;99:120\u20132.","journal-title":"Lung Cancer"},{"issue":"1","key":"1950_CR138","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12967-022-03331-9","volume":"20","author":"Y Yi","year":"2022","unstructured":"Yi Y, Cai J, Xu P, Xiong L, Lu Z, Zeng Z, et al. Potential benefit of osismertinib plus bevacizumab in leptomeningeal metastasis with EGFR mutant non-small-cell lung cancer. J Transl Med. 2022;20(1):122.","journal-title":"J Transl Med"},{"issue":"1","key":"1950_CR139","doi-asserted-by":"publisher","first-page":"344","DOI":"10.4143\/crt.2021.1603","volume":"55","author":"HR Kim","year":"2023","unstructured":"Kim HR, Jo H, Kim H, Hong J, Park S, Jung HA, et al. Osimertinib combined with systemic chemotherapy for EGFR Mutant, T790M-negative, non-small cell lung cancer patients who develop leptomeningeal metastases with extracranial progression to Prior EGFR TKI. Cancer Res Treat. 2023;55(1):344\u20139.","journal-title":"Cancer Res Treat"},{"issue":"4","key":"1950_CR140","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1093\/neuonc\/noz201","volume":"22","author":"E Le Rhun","year":"2020","unstructured":"Le Rhun E, Wallet J, Mailliez A, Le Deley MC, Rodrigues I, Boulanger T, et al. Intrathecal liposomal cytarabine plus systemic therapy versus systemic chemotherapy alone for newly diagnosed leptomeningeal metastasis from breast cancer. Neuro Oncol. 2020;22(4):524\u201338.","journal-title":"Neuro Oncol"},{"issue":"2","key":"1950_CR141","doi-asserted-by":"publisher","first-page":"658","DOI":"10.4103\/jcrt.jcrt_2071_23","volume":"20","author":"S Huang","year":"2024","unstructured":"Huang S, Kang X, Wang C, Zhang W, Jiang J, Kang Z, et al. Outcomes, responses, and prognostic analyses of intrathecal combined treatment for leptomeningeal metastasis from lung adenocarcinoma. J Cancer Res Ther. 2024;20(2):658\u201364.","journal-title":"J Cancer Res Ther"},{"issue":"8","key":"1950_CR142","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1002\/ijc.30214","volume":"139","author":"Z Pan","year":"2016","unstructured":"Pan Z, Yang G, He H, Zhao G, Yuan T, Li Y, et al. Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: a prospective and single-arm study. Int J Cancer. 2016;139(8):1864\u201372.","journal-title":"Int J Cancer"},{"issue":"2","key":"1950_CR143","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00701-021-04763-w","volume":"164","author":"YH Su","year":"2022","unstructured":"Su YH, Chiang CL, Yang HC, Hu YS, Chen YW, Luo YH, et al. Cerebrospinal fluid diversion and outcomes for lung cancer patients with leptomeningeal carcinomatosis. Acta Neurochir (Wien). 2022;164(2):459\u201367.","journal-title":"Acta Neurochir (Wien)"},{"issue":"3","key":"1950_CR144","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s11060-021-03827-2","volume":"154","author":"ED Bander","year":"2021","unstructured":"Bander ED, Yuan M, Reiner AS, Garton ALA, Panageas KS, Brennan CW, et al. Cerebrospinal fluid diversion for leptomeningeal metastasis: palliative, procedural and oncologic outcomes. J Neurooncol. 2021;154(3):301\u201313.","journal-title":"J Neurooncol"},{"issue":"5","key":"1950_CR145","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.mehy.2015.02.009","volume":"84","author":"XH Zhang","year":"2015","unstructured":"Zhang XH, Wang XG, Piao YZ, Wang P, Li P, Li WL. Lumboperitoneal shunt for the treatment of leptomeningeal metastasis. Med Hypotheses. 2015;84(5):506\u20138.","journal-title":"Med Hypotheses"},{"issue":"1","key":"1950_CR146","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1177\/0269216316649128","volume":"31","author":"S Yamashiro","year":"2017","unstructured":"Yamashiro S, Hitoshi Y, Tajiri S, Uchikawa H, Ito K, Yoshida A, et al. Palliative lumboperitoneal shunt for leptomeningeal metastasis-related hydrocephalus: a case series. Palliat Med. 2017;31(1):93\u20136.","journal-title":"Palliat Med"},{"issue":"1","key":"1950_CR147","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2017-000283","volume":"3","author":"IC Glitza","year":"2018","unstructured":"Glitza IC, Rohlfs M, Guha-Thakurta N, Bassett RL Jr, Bernatchez C, Diab A, et al. Retrospective review of metastatic melanoma patients with leptomeningeal disease treated with intrathecal interleukin-2. ESMO Open. 2018;3(1): e000283.","journal-title":"ESMO Open"},{"issue":"2","key":"1950_CR148","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.canlet.2009.10.020","volume":"291","author":"C Gu","year":"2010","unstructured":"Gu C, Li S, Tokuyama T, Yokota N, Namba H. Therapeutic effect of genetically engineered mesenchymal stem cells in rat experimental leptomeningeal glioma model. Cancer Lett. 2010;291(2):256\u201362.","journal-title":"Cancer Lett"},{"issue":"6","key":"1950_CR149","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/s41417-023-00588-0","volume":"30","author":"D Kuruppu","year":"2023","unstructured":"Kuruppu D, Bhere D, Farrar CT, Shah K, Brownell AL, Mahmood U, et al. Oncolytic HSV1 targets different growth phases of breast cancer leptomeningeal metastases. Cancer Gene Ther. 2023;30(6):833\u201344.","journal-title":"Cancer Gene Ther"},{"issue":"10","key":"1950_CR150","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/cgt.2015.43","volume":"22","author":"D Kuruppu","year":"2015","unstructured":"Kuruppu D, Tanabe KK. HSV-1 as a novel therapy for breast cancer meningeal metastases. Cancer Gene Ther. 2015;22(10):506\u20138.","journal-title":"Cancer Gene Ther"},{"issue":"3","key":"1950_CR151","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/BF00736408","volume":"1","author":"T Kawaguchi","year":"1983","unstructured":"Kawaguchi T, Kawaguchi M, Miner KM, Lembo TM, Nicolson GL. Brain meninges tumor formation by in vivo-selected metastatic B16 melanoma variants in mice. Clin Exp Metastasis. 1983;1(3):247\u201359.","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"1950_CR152","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1365-2613.2007.00563.x","volume":"89","author":"N Saito","year":"2008","unstructured":"Saito N, Hatori T, Murata N, Zhang ZA, Nonaka H, Aoki K, et al. Comparison of metastatic brain tumour models using three different methods: the morphological role of the pia mater. Int J Exp Pathol. 2008;89(1):38\u201344.","journal-title":"Int J Exp Pathol"},{"issue":"2","key":"1950_CR153","first-page":"521","volume":"42","author":"X Yu","year":"2019","unstructured":"Yu X, Zhang H, Yuan M, Zhang P, Wang Y, Zheng M, et al. Identification and characterization of a murine model of BCR-ABL1+ acute B-lymphoblastic leukemia with central nervous system metastasis. Oncol Rep. 2019;42(2):521\u201332.","journal-title":"Oncol Rep"},{"key":"1950_CR154","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s40478-014-0085-y","volume":"2","author":"NC Jenkins","year":"2014","unstructured":"Jenkins NC, Kalra RR, Dubuc A, Sivakumar W, Pedone CA, Wu X, et al. Genetic drivers of metastatic dissemination in sonic hedgehog medulloblastoma. Acta Neuropathol Commun. 2014;2:85.","journal-title":"Acta Neuropathol Commun"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-01950-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-01950-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-01950-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T06:58:59Z","timestamp":1740725939000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-01950-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":154,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1950"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-01950-4","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"25 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"254"}}